Published On : 26 Sep 2016
QYResearchReports.com now features a market intelligence report, titled “Global Additional Nuclear Medicine System Sales Market Report 2021.” The report presents an in-depth analysis of the global additional nuclear medicine market and has been compiled using information provided by various stakeholders including CEOs, investors, suppliers, and traders. It serves as a resource to provide financial and technical details to existing and new players in the market.
The rising prevalence of cardiac disorders, cancer, neurological disorders, and diseases associated with aging population is boosting the demand for additional nuclear medicine systems. Moreover, the development of new and advanced products over the past few years has introduced improved nuclear medicine procedures. Other factors fuelling the growth of the global additional nuclear medicine system market are the growing awareness about the importance of early diagnosis of diseases, development of new radiotracers, and investments in the modernization of diagnostic imaging centers.
On the other hand, the rising adoption of refurbished diagnostic imaging systems along with hospital budget constraints is posing a serious threat to the additional nuclear medicine system manufacturers. Furthermore, the high cost of nuclear medicine equipment, shorter half-life of radiopharmaceuticals, and unfavorable healthcare reforms in several countries including the U.S. are limiting the demand for these systems. These factors, collectively, are hampering the growth of the market. However, the increasing adoption of nuclear medicine procedures in emerging markets and presence of strong products in the pipeline are likely to propel the growth of the market in the forthcoming years.
To get sample copy of report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=791209&type=E
On the basis of geography, the market is segmented into North America, Japan, China, Europe, Southeast Asia, and India. Each regional market is reviewed based on its sales, value, growth rate, and market shares from 2011 to 2021. North America is expected to be the leading additional nuclear medicine system market throughout the period under study. By type, the market is segmented into G-Scan Brio, O-Scan, and S-Scan. The report focuses on these segments’ revenue, sales, price, growth rate, and market share at the global and regional level during the same period. In terms of applications, the market is categorized into healthy, hospital, and diagnosis. These segments are analyzed on the basis of their market share, growth rate, and sales globally as well as regionally between 2011 and 2021.
The report provides a comprehensive evaluation of the competitive landscape and profiles of key players in the global additional nuclear medicine system market. It studies the overall sales of additional nuclear medicine systems in the global market and across the aforementioned regions along with their price, revenue, sales, market share, and projected growth trajectory for each key player. Some of the key players mentioned in the report are Agfa Healthcare, Biosound Esaote Inc., Carestream Health, Fujifilm Medical Systems U.S.A., GE Healthcare, Hitachi Medical Systems, Konica Minolta Medical Imaging, Philips Healthcare, Siemens Healthcare, and Toshiba Medical Systems Corporation.